非小细胞肺癌中医药治疗研究进展  

Research progress in traditional Chinese medicine treatment of non-small cell lung cancer

作　　者：王军徽 肖萌 马功贤 王凯[1,2] WANG Junhui;XIAO Meng;MA Gongxian;WANG Kai(Shaanxi University of Chinese Medicine,Xianyang 712046,China)

机构地区：[1]陕西中医药大学,陕西咸阳712046 [2]西安市长安区医院,陕西西安710100

出　　处：《陕西中医》2023年第11期1663-1664,F0003,共3页Shaanxi Journal of Traditional Chinese Medicine

基　　金：西安市市级中医药科研项目(SZJ202009)。

摘　　要：肺癌作为目前人类因癌症死亡的主要原因,其在我国的发病率、病死率均居首位,其中非小细胞肺癌发病率占比最高。肺癌的主要治疗手段有手术、放化疗,但其产生的不良反应严重影响肺癌患者预后。中医认为本病病机以虚为本,邪实为标,痰瘀互结,邪毒内阻,发为本病。治疗主要在扶正为本的基础上,辨证施治,临证加减。根据近年相关文献报道的中医药对非小细胞肺癌病因病机、辨证分型、作用机制、临床治法等探究,分析归纳中医药学研究情况,为本病治疗、预防提供理论依据与参考。Lung cancer as the main cause of cancer-related deaths in human beings at present,still ranks first in our country in morbidity and mortality.Among them,non-small cell lung cancer has the highest incidence rate.The main treatments for lung cancer are surgery,radiotherapy and chemotherapy,but adverse effects generated seriously affect the prognosis of lung cancer patients.According to Chinese medicine,pathogenesis of the disease is based on deficiency,and evil substance is the symptom.Phlegm and stasis are intertwined with each other,and internal obstruction of evil and toxicity occurs,which results in the development of the disease.The treatment is mainly based on Fuzheng,treating the disease by recognizing the evidence and adding and subtracting according to the evidence.The etiology and pathogenesis,differentiation and typing,mechanism and clinical treatment of non-small cell lung cancer by Chinese medicine are reviewed according to the literature in recent years,so as to provide theoretical basis for the clinical treatment and prevention of non-small cell lung cancer.

关 键 词：非小细胞肺癌 虚证 实证 痰瘀互结 邪毒内阻 

分 类 号：R734.2[医药卫生—肿瘤]